SHAN; Bei

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHAN; Bei.The latest application filed is for "method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)".

Company Profile

3.32.47

SHAN; Bei - Redwood City CA
Shan; Bei - South San Francisco CA
Shan, Bei - Foster City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treating Or Ameliorating Metabolic Disorders Using Growth Differentiation Factor 15 (gdf-15) App 20200325200 - XIONG; Yumei ; et al.	2020-10-15
Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15) Grant 10,752,664 - Xiong , et al. A	2020-08-25
Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 9,920,134 - Jackson , et al. March 20, 2	2018-03-20
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 9,493,576 - Jackson , et al. November 15, 2	2016-11-15
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 9,056,915 - Jackson , et al. June 16, 2	2015-06-16
Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 9,045,547 - Jackson , et al. June 2, 2	2015-06-02
Modified lecithin-cholesterol acyltransferase enzymes Grant 9,006,408 - Zhou , et al. April 14, 2	2015-04-14
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20150087819 - JACKSON; SIMON MARK ; et al.	2015-03-26
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 8,981,064 - Jackson , et al. March 17, 2	2015-03-17
Nucleic Acid Encoding Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140357850 - Jackson; Simon Mark ; et al.	2014-12-04
Nucleic Acid Encoding Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140357852 - Jackson; Simon Mark ; et al.	2014-12-04
Nucleic Acid Encoding Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140357854 - Jackson; Simon Mark ; et al.	2014-12-04
Nucleic Acid Encoding Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140357851 - Jackson; Simon Mark ; et al.	2014-12-04
Nucleic Acid Encoding Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140357853 - Jackson; Simon Mark ; et al.	2014-12-04
Modified Lecithin-cholesterol Acyltransferase Enzymes App 20140287479 - Zhou; Mingyue ; et al.	2014-09-25
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140228547 - Jackson; Simon Mark ; et al.	2014-08-14
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140228557 - Jackson; Simon Mark ; et al.	2014-08-14
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20140228545 - Jackson; Simon Mark ; et al.	2014-08-14
Modified lecithin-cholesterol acyltransferase enzymes Grant 8,703,926 - Zhou , et al. April 22, 2	2014-04-22
Methods For Treating Atherosclerosis App 20130273024 - KAYSER; Frank ; et al.	2013-10-17
Methods for treating atherosclerosis Grant 8,426,358 - Kayser , et al. April 23, 2	2013-04-23
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130085265 - JACKSON; SIMON MARK ; et al.	2013-04-04
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130079502 - JACKSON; SIMON MARK ; et al.	2013-03-28
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130079501 - JACKSON; SIMON MARK ; et al.	2013-03-28
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130072665 - Jackson; Simon Mark ; et al.	2013-03-21
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130058944 - Jackson; Simon Mark ; et al.	2013-03-07
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20130052201 - Jackson; Simon Mark ; et al.	2013-02-28
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120251544 - Jackson; Simon Mark ; et al.	2012-10-04
Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides Grant 8,257,934 - Tian , et al. September 4, 2	2012-09-04
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120213797 - Jackson; Simon Mark ; et al.	2012-08-23
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 8,168,762 - Jackson , et al. May 1, 2	2012-05-01
Modified lecithin-cholesterol acyltransferase enzymes Grant 8,168,416 - Boone , et al. May 1, 2	2012-05-01
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120093818 - Jackson; Simon Mark ; et al.	2012-04-19
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120027765 - Jackson; Simon Mark ; et al.	2012-02-02
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120020976 - Jackson; Simon Mark ; et al.	2012-01-26
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20120020975 - Jackson; Simon Mark ; et al.	2012-01-26
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) Grant 8,030,457 - Jackson , et al. October 4, 2	2011-10-04
Methods For Treating Atherosclerosis App 20110206652 - Kayser; Frank ; et al.	2011-08-25
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20110027287 - JACKSON; SIMON MARK ; et al.	2011-02-03
Screening Methods Using Sitosterolemia Susceptibility Gene (ssg) Polypeptides App 20100184096 - TIAN; Hui ; et al.	2010-07-22
Sitosterolemia susceptibility gene (SSG): compositions and methods of use Grant 7,662,376 - Tian , et al. February 16, 2	2010-02-16
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20090326202 - Jackson; Simon Mark ; et al.	2009-12-31
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (pcsk9) App 20090142352 - Jackson; Simon Mark ; et al.	2009-06-04
FXR modulators Grant 7,511,043 - Houze , et al. March 31, 2	2009-03-31
Modified Lecithin-Cholesterol Acyltransferase Enzymes App 20090081182 - BOONE; Tom ; et al.	2009-03-26
Methods for treating atherosclerosis App 20080096900 - Kayser; Frank ; et al.	2008-04-24
Sitosterolemia susceptibility gene (SSG): compositions and methods of use App 20080009608 - Tian; Hui ; et al.	2008-01-10
Sitosterolemia susceptibility gene (SSG) polypeptides Grant 7,229,816 - Tian , et al. June 12, 2	2007-06-12
Pentafluorobenzenesulfonamides and analogs Grant 7,138,418 - Flygare , et al. November 21, 2	2006-11-21
Cell-based drug screens for regulators of gene expression Grant 7,105,313 - Shan , et al. September 12, 2	2006-09-12
Nuclear hormone receptor drug screens Grant 7,101,681 - Lustig , et al. September 5, 2	2006-09-05
Sitosterolemia susceptibility gene (SSG): compositions and methods of use Grant 7,033,810 - Tian , et al. April 25, 2	2006-04-25
Pentafluorobenzenesulfonamides and analogs Grant 6,962,929 - Flygare , et al. November 8, 2	2005-11-08
Sitosterolemia susceptibility gene (SSG): compositions and methods of use App 20050214850 - Tian, Hui ; et al.	2005-09-29
LXR modulators Grant 6,906,069 - Li , et al. June 14, 2	2005-06-14
ABCG8 vectors, host cells, and method of making Grant 6,821,750 - Hobbs , et al. November 23, 2	2004-11-23
FXR modulators App 20040176426 - Houze, Jonathan ; et al.	2004-09-09
FXR modulators Grant 6,777,446 - Houze , et al. August 17, 2	2004-08-17
Pentafluorobenzenesulfonamides and analogs App 20030162817 - Flygare, John A. ; et al.	2003-08-28
Cell-based drug screens for regulators of gene expression App 20030153025 - Shan, Bei ; et al.	2003-08-14
ABCG5 and ABCG8: compositions and methods of use App 20030049730 - Hobbs, Helen H. ; et al.	2003-03-13
FXR receptor-mediated modulation of cholesterol metabolism App 20030003520 - Shan, Bei ; et al.	2003-01-02
FXR receptor-mediated modulation cholesterol metabolism Grant 6,465,258 - Shan , et al. October 15, 2	2002-10-15
Pentafluorobenzenesulfonamides and analogs App 20020143036 - Flygare, John A ; et al.	2002-10-03
FXR modulators App 20020120137 - Houze, Jonathan ; et al.	2002-08-29
Therapeutic agent for hyperlipidemia App 20020119958 - Tojo, Shinichiro ; et al.	2002-08-29
Sitosterolemia susceptibility gene (SSG): compositions and methods of use App 20020081687 - Tian, Hui ; et al.	2002-06-27
Treatment of hypertriglyceridemia and other conditions using LXR modulators App 20020048572 - Shan, Bei ; et al.	2002-04-25
Benzene compounds as antiproliferative and cholesterol lowering agents App 20020013496 - Medina, Julio Cesar ; et al.	2002-01-31
LXR modulators Grant 6,316,503 - Li , et al. November 13, 2	2001-11-13
Substituted benzene compounds as antiproliferative and cholesterol lowering action Grant 6,284,923 - Medina , et al. September 4, 2	2001-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.